UK Companies House feature
VETERINARY PATHOLOGY GROUP LIMITED
Profile
- Company number
- 11006776
- Status
- Active
- Incorporation
- 2017-10-11
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 75000
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Blick Rothenberg Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have a reasonable expectation that the company will continue in operational existence for the foreseeable future. The expectation is based on the most recent budget, latest forecast and customer commitments leading the directors to support the going concern basis. This is for a period at least 12 months from signing of the accounts and beyond. The company has also received a letter of support from the parent company.”
Subsidiaries
- Veterinary Pathology Group Ireland Limited · 100% held · Ireland · Veterinary pathology activities
Significant events
- “The Company was acquired by JAB Pet Labs Limited on 30 September 2022.”
- “Trading conditions in 2024 continued to be challenging, reflecting global economic conditions and pressures in the wider veterinary sector.”
- “Revenue in 2024 declined by 8.5% compared to the prior year, reflecting a decrease in test volumes, customer churn and pricing pressures.”
- “Significant investments in upgrading software platforms resulted in increased depreciation and amortisation charges incurred in the year.”
- “The Company incurred an operating loss of £1,439,262 in 2024 (2023: profit of £150,414).”
- “An unsecured revolving credit facility was advanced by the parent entity during the year.”
- “JAB Holding Company Group is committed to being carbon neutral by 2025; VPG plans to reduce carbon emissions through new contracts, including rolling out hybrid vehicles starting May 2024.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BACKMANN, Ben, Dr | Director | 2025-11-10 | Mar 1975 | German |
| BHAT, Kavita | Director | 2025-11-10 | May 1979 | American |
| BILLINGTON, Julie Ann Louise | Director | 2025-11-10 | May 1970 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AMBROSE, Chris | Director | 2022-09-29 | 2022-10-18 |
| DIAMOND, Mark John | Director | 2017-11-01 | 2019-03-01 |
| DOLLAR, Mark Peter Frederick | Director | 2017-10-11 | 2022-09-30 |
| EVANS, Thomas Edward | Director | 2018-03-13 | 2022-09-30 |
| FLOREANI, Mathieu Olivier | Director | 2017-12-01 | 2020-12-09 |
| GOSLING, Fiona, Dr | Director | 2021-09-09 | 2025-11-10 |
| GUÉNY, Arnaud | Director | 2018-04-13 | 2020-12-09 |
| HOOGEVEEN, Luuk | Director | 2022-10-18 | 2025-01-16 |
| MEYER, Konrad Fano | Director | 2022-09-30 | 2025-11-10 |
| NENOVA, Yoana Antonieva | Director | 2022-09-30 | 2025-11-10 |
| QUIN, Stuart James | Director | 2017-10-11 | 2018-04-13 |
| STOPFORD, Nicholas John | Director | 2017-10-31 | 2018-03-13 |
| TORRANCE, Andrew Graham, Dr | Director | 2017-11-01 | 2021-08-21 |
| WARWEG, Sebastian | Director | 2022-10-18 | 2025-01-16 |
| YOUNG, Dominic Cosmas Samson | Director | 2024-11-20 | 2025-11-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Zoetis Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-11-10 | Active |
| Jab Pet Labs Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-12-09 | Ceased 2025-11-10 |
| Labco Uk Group Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2017-10-11 | Ceased 2022-09-30 |
Filing timeline
Last 20 of 70 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-27 | RESOLUTIONS | resolution | resolution |
| 2025-12-27 | MA | incorporation | memorandum articles |
| 2025-11-18 | AP01 | officers | appoint person director company with name date |
| 2025-11-18 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-11-14 | AP01 | officers | appoint person director company with name date |
| 2025-11-13 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-11-13 | AD01 | address | change registered office address company with date old address new address |
| 2025-11-13 | TM01 | officers | termination director company with name termination date |
| 2025-11-13 | TM01 | officers | termination director company with name termination date |
| 2025-11-13 | TM01 | officers | termination director company with name termination date |
| 2025-11-13 | AP01 | officers | appoint person director company with name date |
| 2025-11-13 | TM01 | officers | termination director company with name termination date |
| 2025-11-11 | RP01CS01 | confirmation-statement | replacement filing of confirmation statement with made up date |
| 2025-11-07 | RP01CS01 | confirmation-statement | replacement filing of confirmation statement with made up date |
| 2025-11-07 | RP01SH01 | miscellaneous | legacy |
| 2025-10-27 | CS01 | confirmation-statement | confirmation statement |
| 2025-10-07 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2025-10-07 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-10-07 | PSC09 | persons-with-significant-control | withdrawal of a person with significant control statement |
| 2025-09-25 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory